STOCK TITAN

Buda Juice (BUDA) 10-K Filings

BUDA NYSE

Here are the 10-K annual reports from Buda Juice, Inc. (BUDA) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-K covers the audited annual report, with the full financial statements, so if you follow BUDA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BUDA filings page.

Rhea-AI Summary

Buda Juice, Inc. files its annual report for the year ended December 31, 2025, outlining a profitable but highly concentrated fresh-juice business. The company pioneers UltraFresh™ cold-crafted citrus juices and wellness shots, using a strict 35°F end-to-end cold chain and an asset-light logistics model serving grocery retailers in Texas.

Buda plans a three-hub expansion, adding projected facilities in South Carolina and Arizona/Nevada to reach more U.S. consumers. For 2025 and 2024, it reports net profit of $3.53 million and $3.57 million, respectively, with 39 full-time employees as of December 31, 2025.

Risk disclosures highlight reliance on one customer for 97% of 2025 net sales, exposure to fresh citrus supply and climate, short shelf-life and cold-chain complexity, food safety and regulatory compliance, inflationary logistics costs, and the added burden of public-company governance. Common stock trades on NYSE American under the symbol BUDA, with 12,566,666 shares outstanding as of March 26, 2026.